Erosive Esophagitis
📧 Sign up to get email alerts when something new happens for Erosive Esophagitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-10-18FDA Approved: PREVACID SOLUTAB — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Prevacid Solutab (lansoprazole) by Takeda Pharmaceuticals America, Inc., related to the Solu…
-
FDA approval · 2017-10-17FDA Approved: DEXILANT — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Dexilant (dexlansoprazole) from Takeda Pharmaceuticals America, resulting in changes to the prod…
-
FDA approval · 2017-09-28FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for omeprazole by Sandoz Inc (ANDA 076515).
-
FDA approval · 2017-09-21FDA Approved: LANSOPRAZOLE — Original Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's original ANDA for lansoprazole, enabling a generic version to be marketed for acid-related disorders.
-
CLINICAL_TRIALS trial_result · 2017-09-12Clinical Trial Update: Study to Confirm the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis [Phase 3]
A Phase 3 study evaluating CJ-12420 for safety and efficacy in erosive esophagitis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-08-30FDA Approved: LANSOPRAZOLE — Original Application (Lifestar Pharma LLC.)
FDA approves a generic lansoprazole under an Original Application (ANDA) for Lifestar Pharma LLC.
-
FDA approval · 2017-08-18FDA Approved: KIRKLAND SIGNATURE ESOMEPRAZOLE MAGNESIUM — Original Application (Costco Wholesale Company)
The FDA approved the original generic application for Kirkland Signature Esomeprazole Magnesium, a generic version of esomeprazole magnesium…
-
FDA approval · 2017-07-06FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for Protonix Delayed-Release (pantoprazole sodium) from Wyeth/Pfizer to update the drug's labeling.
-
FDA approval · 2017-07-06FDA Approved: PROTONIX I.V. — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application to authorize the intravenous formulation of Protonix (pantoprazole sodium) for specified indicat…
-
FDA approval · 2017-07-05FDA Approved: BERKLEY AND JENSEN OMEPRAZOLE — Original Application (BJWC)
FDA approved Berkley and Jensen Omeprazole under an original application; the product is a proton pump inhibitor indicated for gastroesophag…
-
FDA approval · 2017-07-03FDA Approved: OMEPRAZOLE — Original Application (Golden State Medical Supply, Inc.)
FDA approves a generic omeprazole from Golden State Medical Supply, Inc. under an Original Application (ANDA 203481).
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: To Evaluate Efficacy and Safety of Z-215 in Erosive Esophagitis [Phase 2]
Zeria Pharmaceutical completed a Phase 2 clinical trial evaluating the efficacy and safety of Z-215 in erosive esophagitis. The study enroll…
-
FDA approval · 2017-06-30FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Civica, Inc.)
The FDA approved Civica, Inc.'s pantoprazole sodium original application (NDA 209463), a proton pump inhibitor for acid-related conditions a…
-
FDA approval · 2017-06-26FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (XLCare Pharmaceuticals Inc.)
FDA approved a supplemental application for pantoprazole sodium by XLCare Pharmaceuticals Inc., validating continued approval of their panto…
-
FDA approval · 2017-05-09FDA Approved: EQUATE LANSOPRAZOLE — Supplemental Application (Wal-Mart Stores Inc)
FDA approved a supplemental application for Equate Lansoprazole (lansoprazole) from Wal-Mart Stores Inc, related to this generic product.
-
FDA approval · 2017-04-19FDA Approved: DEXLANSOPRAZOLE — Original Application (ENDO USA, Inc.)
FDA approved ENDO USA, Inc.'s original application for dexlansoprazole (DEXLANSOPRAZOLE) as a generic on ANDA 202294. The therapy is used fo…
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: To Learn How Bone Structure and Bone Mass Change After Long-term PPI Use
A completed clinical trial from the University of Pennsylvania investigates how bone structure and bone mass change with long-term proton pu…
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Proton Pump Inhibitor (PPI) Responsive Eosinophilic Esophagitis EoE: Gastroesophageal Reflux Disease (GERD) or Eosinophilic Esophagitis (EoE)?
A Mayo Clinic-sponsored study on proton pump inhibitor-responsive eosinophilic esophagitis has completed, investigating whether PPI response…
-
FDA approval · 2017-02-17FDA Approved: RABEPRAZOLE SODIUM — Original Application (Aurobindo Pharma Limited)
FDA approved an original ANDA for a generic rabeprazole sodium product from Aurobindo Pharma Limited.
-
FDA approval · 2017-02-07FDA Approved: RANITIDINE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for ranitidine from Amneal Pharmaceuticals of New York LLC (ANDA 077824).
-
FDA approval · 2017-01-09FDA Approved: NEXIUM 24HR CLEARMINIS — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application to add NEXIUM 24HR CLEARMINIS (esomeprazole magnesium) to Haleon US Holdings LLC's Nexium product li…
-
CLINICAL_TRIALS trial_result · 2016-12-16Clinical Trial Update: A Study to Compare the Pharmacokinetic Characteristics of CJ-12420 [Phase 1]
Phase 1 trial evaluating the pharmacokinetic characteristics of CJ-12420 for erosive esophagitis; the study sponsored by HK inno.N Corporati…
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis [Phase 3]
A Phase 3 clinical trial evaluating CJ-12420 for safety and efficacy in erosive esophagitis has completed.
-
FDA approval · 2016-12-06FDA Approved: OMEPRAZOLE SODIUM BICARBONATE — Original Application (Cipla USA Inc.)
FDA approves Cipla USA Inc.'s original application for Omeprazole Sodium Bicarbonate (generic). This is a generic omeprazole-sodium bicarbon…
-
FDA approval · 2016-12-01FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
The FDA approved a supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole) from AmerisourceBergen, updating labeling and…